Historical Valuation
OrthoPediatrics Corp (KIDS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.72 is considered Undervalued compared with the five-year average of -42.72. The fair price of OrthoPediatrics Corp (KIDS) is between 306.60 to 361.99 according to relative valuation methord. Compared to the current price of 18.31 USD , OrthoPediatrics Corp is Undervalued By 94.03%.
Relative Value
Fair Zone
306.60-361.99
Current Price：18.31
94.03%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
OrthoPediatrics Corp (KIDS) has a current Price-to-Book (P/B) ratio of 1.26. Compared to its 3-year average P/B ratio of 1.90 , the current P/B ratio is approximately -33.70% higher. Relative to its 5-year average P/B ratio of 2.95, the current P/B ratio is about -57.22% higher. OrthoPediatrics Corp (KIDS) has a Forward Free Cash Flow (FCF) yield of approximately -6.68%. Compared to its 3-year average FCF yield of -6.00%, the current FCF yield is approximately 11.47% lower. Relative to its 5-year average FCF yield of -4.57% , the current FCF yield is about 46.18% lower.
P/B
Median3y
1.90
Median5y
2.95
FCF Yield
Median3y
-6.00
Median5y
-4.57
Competitors Valuation Multiple
AI Analysis for KIDS
The average P/S ratio for KIDS competitors is 116.45, providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS.O) exhibits a P/S ratio of 1.72, which is -98.52% above the industry average. Given its robust revenue growth of 12.23%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for KIDS
1Y
3Y
5Y
Market capitalization of KIDS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of KIDS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is KIDS currently overvalued or undervalued?
OrthoPediatrics Corp (KIDS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.72 is considered Undervalued compared with the five-year average of -42.72. The fair price of OrthoPediatrics Corp (KIDS) is between 306.60 to 361.99 according to relative valuation methord. Compared to the current price of 18.31 USD , OrthoPediatrics Corp is Undervalued By 94.03% .
What is OrthoPediatrics Corp (KIDS) fair value?
KIDS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of OrthoPediatrics Corp (KIDS) is between 306.60 to 361.99 according to relative valuation methord.
How does KIDS's valuation metrics compare to the industry average?
The average P/S ratio for KIDS's competitors is 116.45, providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS) exhibits a P/S ratio of 1.72, which is -98.52% above the industry average. Given its robust revenue growth of 12.23%, this premium appears unsustainable.
What is the current P/B ratio for OrthoPediatrics Corp (KIDS) as of Jan 10 2026?
As of Jan 10 2026, OrthoPediatrics Corp (KIDS) has a P/B ratio of 1.26. This indicates that the market values KIDS at 1.26 times its book value.
What is the current FCF Yield for OrthoPediatrics Corp (KIDS) as of Jan 10 2026?
As of Jan 10 2026, OrthoPediatrics Corp (KIDS) has a FCF Yield of -6.68%. This means that for every dollar of OrthoPediatrics Corp’s market capitalization, the company generates -6.68 cents in free cash flow.
What is the current Forward P/E ratio for OrthoPediatrics Corp (KIDS) as of Jan 10 2026?
As of Jan 10 2026, OrthoPediatrics Corp (KIDS) has a Forward P/E ratio of -13.35. This means the market is willing to pay $-13.35 for every dollar of OrthoPediatrics Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for OrthoPediatrics Corp (KIDS) as of Jan 10 2026?
As of Jan 10 2026, OrthoPediatrics Corp (KIDS) has a Forward P/S ratio of 1.72. This means the market is valuing KIDS at $1.72 for every dollar of expected revenue over the next 12 months.